Evidence map›Paper›PMID 28676523›Full record

ArticleThe Journal of endocrinology2017

Macrophage 11β-HSD-1 deficiency promotes inflammatory angiogenesis.

Zhenguang Zhang, Agnes E Coutinho, Tak Yung Man, Tiina M J Kipari, Patrick W F Hadoke, Donald M Salter, Jonathan R Seckl, Karen E Chapman

Open access · hybridAbstract read
In one paragraph

Article in The Journal of endocrinology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 20 citations in OpenAlex.

  1. Knockout ofZoological research · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Zhenguang ZhangUniversity/BHF Centre for Cardiovascular ScienceThe Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, UK.
Agnes E CoutinhoUniversity/BHF Centre for Cardiovascular ScienceThe Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, UK.
Tak Yung ManUniversity/BHF Centre for Cardiovascular ScienceThe Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, UK.
Tiina M J KipariCentre for Genomic and Experimental MedicineMRC Institute of Genetic and Molecular Medicine, The University of Edinburgh, Western General Hospital, Edinburgh, UK.
Patrick W F HadokeUniversity/BHF Centre for Cardiovascular ScienceThe Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, UK.
Donald M SalterCentre for Genomic and Experimental MedicineMRC Institute of Genetic and Molecular Medicine, The University of Edinburgh, Western General Hospital, Edinburgh, UK.
Jonathan R SecklUniversity/BHF Centre for Cardiovascular ScienceThe Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, UK.
Karen E ChapmanUniversity/BHF Centre for Cardiovascular ScienceThe Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, UK Karen.Chapman@ed.ac.uk.
The Queen's Medical Research Institute · GBUniversity of Edinburgh · GBWestern General Hospital · GB

Funding

Medical Research Council G0800235
6 · The paper itself

Abstract

11β-Hydroxysteroid dehydrogenase-1 (11β-HSD1) predominantly converts inert glucocorticoids into active forms, thereby contributing to intracellular glucocorticoid levels. 11β-HSD1 is dynamically regulated during inflammation, including in macrophages where it regulates phagocytic capacity. The resolution of inflammation in some disease models including inflammatory arthritis is impaired by 11β-HSD1 deficiency or inhibition. However, 11β-HSD1 deficiency/inhibition also promotes angiogenesis, which is beneficial in mouse models of surgical wound healing, myocardial infarction or obesity. The cell types responsible for the anti-inflammatory and anti-angiogenic roles of 11β-HSD1 have not been characterised. Here, we generated

Indexed as

11-beta-Hydroxysteroid Dehydrogenase Type 1AnimalsHumansInflammationMacrophagesMiceNeovascularization, Pathologic11-beta-Hydroxysteroid Dehydrogenase Type 111β-HSD1glucocorticoidinflammationmacrophagesteroid metabolism

Identifiers

PMID28676523
PMCPMC5574305
OpenAlexW2728804974

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.